|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"楊志新"
Showing items 101-125 of 209 (9 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 > >>
View [10|25|50] records per page
| 國立臺灣大學 |
2012 |
Survival Following Surgery with or without Adjuvant Chemotherapy for Stage I-IIIA Non-Small Cell Lung Cancer: An East Asian Population-Based Study
|
Lin, Zhong-Zhe; Shau, Wen-Yi; Shao, Yu-Yun; Yang, Yen-Yun; Kuo, Raymond Nien-Chen; Yang, James Chih-Hsin; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 林宗哲 |
| 國立臺灣大學 |
2012 |
Survival of Patients with Small Cell Lung Carcinoma in Taiwan
|
Kuo, Yu-Hsuan; Lin, Zhong-Zhe; Yang, Yen-Yun; Shao, Yu-Yun; Shau, Wen-Yi; Kuo, Raymond N. C.; Yang, James Chih-Hsin; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 林宗哲; 郭年真 |
| 國立臺灣大學 |
2012 |
Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma
|
Girard, N.; Sima, C. S.; Jackman, D. M.; Sequist, L. V.; Chen, H.; Yang, J. C-H.; Ji, H.; Waltman, B.; Rosell, R.; Taron, M.; Zakowski, M. F.; Ladanyi, M.; Riely, G.; Pao, W.; 楊志新 |
| 國立臺灣大學 |
2012 |
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial
|
Miller, Vincent A.; Hirsh, Vera; Cadranel, Jacques; Chen, Yuh-Min; Park, Keunchil; Kim, Sang-We; Zhou, Caicun; Su, Wu-Chou; Wang, Mengzhao; Sun, Yan; Heo, Dae Seog; Crino, Lucio; Tan, Eng-Huat; Chao, Tsu-Yi; Shahidi, Mehdi; Cong, Xiuyu Julie; Lorence, Robert M.; Yang, James Chih-Hsin; 楊志新 |
| 國立臺灣大學 |
2011 |
Comparison of the Quality of Life between Patients with Non-Small-Cell Lung Cancer and Healthy Controls
|
李俊賢; 張郁瑩; 李元麒; 楊志新; 劉紹興; 劉邦祥; 王榮德; LEE, LUKAS JYUHN-HSIARN; CHANG, YU-YIN; LEE, YUNG-CHIE; YANG, CHIH-HSIN; LIOU, SAOU-HSING; LIU, PANG-HSIANG; WANG, JUNG-DER |
| 國立臺灣大學 |
2011 |
Tumour Response, Skin Rash and Health-Related Quality of Life (Hrqol) - Post-Hoc Data from the Ipass Study
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2011 |
Skin Manifestations of Gefitinib and the Association with Survival of Advanced Non-Small-Cell Lung Cancer in Taiwan
|
王修含; 楊志新; 邱顯清; 胡賦?; 詹智傑; 廖怡華; 陳小菁; 朱家瑜; WANG, SHIOU-HAN; YANG, CHIH-HSIN; CHIU, HSIEN-CHING; HU, FU-CHANG; CHAN, CHIH-CHIEH; LIAO, YI-HUA; CHEN, HSIAO-CHIN; CHU, CHIA-YU |
| 國立臺灣大學 |
2011 |
Inspire: A Phase Iii Study of the Blp25 Liposome Vaccine (L-Blp25) in Asian Patients with Unresectable Stage Iii Non-Small Cell Lung Cancer
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2011 |
Phase 2 Trial of Linifanib (Abt-869) in Patients with Advanced Non-Small Cell Lung Cancer
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2011 |
Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non- Small-Cell Lung Cancer: A Randomized, Double-Blind Phase Iii Trial
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2011 |
Health-Related Quality-of-Life in a Randomized Phase Iii First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients from Asia with Advanced Nsclc (Ipass)
|
楊志新; 陳育民; 郭漢彬; YANG, CHIH-HSIN; CHEN, YUH-MIN; KUO, HAN-PIN |
| 國立臺灣大學 |
2011 |
Biomarker Analyses and Final Overall Survival Results from a Phase Iii, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/ Paclitaxel in Clinically Selected Patients with Advanced Non-Small-Cell Lung Cancer in Asia (Ipass)
|
楊志新; 趙祖怡; YANG, CHIH-HSIN; CHAO, TSU-YI |
| 國立臺灣大學 |
2010 |
Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factors
|
陳冠宇; 陳人豪; 施金元; 楊志新; 余忠仁; 楊泮池; CHEN, KUAN-YU; CHEN, JEN-HAU; SHIH, JIN-YUAN; YANG, CHIH-HSIN; YU, CHONG-JEN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2010 |
O-6-Methylguanine-DNA Methyltransferase Expression and Prognostic Value in Brain Metastases of Lung Cancers
|
吳佩芳; 郭冠廷; 郭律廷; 林怡婷; 盧彥伸; 楊志新; 吳瑞美; 杜永光; 蔡瑞章; 曾漢民; 曾勝弘; 鄭安理; 林璟宏; WU, PEI-FANG; KUO, KUAN-TING; KUO, LU-TING; LIN, YI-TING; LU, YEN-SHEN; YANG, CHIH-HSIN; WU, RUEY-MEEI; TU, YONG-KWANG; TSAI, JUI-CHANG; TSENG, HAN-MIN; TSENG, SHENG-HONG; CHENG, ANN-LII; LIN, CHING-HUNG |
| 國立臺灣大學 |
2010 |
Characteristics and Risk Factors of Oxaliplatin-Related Hypersensitivity Reactions
|
邵幼雲; 胡賦强; 邱文姿; 鄭安理; 楊志新; SHAO, YU-YUN; HU, FU-CHANG; CHIU, WEN-TZU; CHENG, ANN-LII; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2010 |
Chemotherapy Response in East Asian Non-Small Cell Lung Cancer Patients Harboring Wild-Type or Activating Mutation of Epidermal Growth Factor Receptors
|
林家齊; 徐心馨; 孫家棟; 施金元; 林宗哲; 余忠仁; 楊志新; LIN, CHIA-CHI; HSU, HSIN-HSIN; SHUN, CHIA-TUNG; SHIH, JIN-YUAN; LIN, ZONG-ZHE; YU, CHONG-JEN; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2010 |
Correlation of F-18 Fluorodeoxyglucose-Positron Emission Tomography Maximal Standardized Uptake Value and Egfr Mutations in Advanced Lung Adenocarcinoma
|
黃俊達; 顏若芳; 鄭媚方; 衛品妃; 蔡怡汝; 蔡孟峰; 施金元; 楊志新; 楊泮池; HUANG, CHUN-TA; YEN, RUOH-FANG; CHENG, MEI-FANG; WEI, PIN-FEI; TSAI, YI-JU; TSAI, MENG-FENG; SHIH, JIN-YUAN; YANG, CHIH-HSIN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2010 |
Influence of First-Line Chemotherapy and Egfr Mutations on Second-Line Gefitinib in Advanced Non-Small Cell Lung Cancer
|
巫震宇; 余忠仁; 施金元; 楊志新; 楊泮池; WU, JENN-YU; YU, CHONG-JEN; SHIH, JIN-YUAN; YANG, CHIH-HSIN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2010 |
Second-Line Treatments after First-Line Gefitinib Therapy in Advanced Nonsmall Cell Lung Cancer
|
巫震宇; 施金元; 楊志新; 陳冠宇; 何肇基; 余忠仁; 楊泮池; WU, JENN-YU; SHIH, JIN-YUAN; YANG, CHIH-HSIN; CHEN, KUAN-YU; HO, CHAO-CHI; YU, CHONG-JEN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2010 |
Use of Cetuximab after Failure of Gefitinib in Patients with Advanced Non- Small-Cell Lung Cancer
|
巫震宇; 楊志新; 余忠仁; 楊泮池; 施金元; WU, JENN-YU; YANG, CHIH-HSIN; YU, CHONG-JEN; SHIH, JIN-YUAN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2010 |
Quality of Life (Qol) in a Randomized Phase Iii First-Line Study of Gefitinib (G) Vs Carboplatin/Paclitaxel (Cp) in Clinically Selected Asian Patients (Pts) with Advanced Nsclc (Ipass)
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2010 |
Final Overall Survival Os Results from a Phase Iii, Randomised, Open-Label , First-Line Study of Gefitinib G V Carboplatin/Paclitaxel C/P in Clinically Selected Patients with Advanced Non-Small Cell Lung Cancer Nsclc in Asia Ipass
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2010 |
Phase 2 Results of Xl184 in a Cohort of Patients Pts with Advanced Non- Small Cell Lung Cancer Nsclc
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Bibw 2992, a Novel Irreversible Egfr/Her2 Tyrosine Kinase Inhibitor, in Chemonaive Patients with Adenocarcinoma of the Lung and Activating Egfr Mutations
|
楊志新; 施金元; 蘇五洲; 夏德椿; YANG, CHIH-HSIN; SHIH, JIN-YUAN; SU, WU- CHOU; HSIA, TE-CHUN |
| 國立臺灣大學 |
2009 |
Clinical Outcomes of Patients with Epidermal Growth Factor Receptor (Egfr ) Mutations (Mut) in Ipass (Iressatm Pan Asia Study)
|
趙祖怡; 楊志新; CHAO, TSU-YI; YANG, CHIH-HSIN |
Showing items 101-125 of 209 (9 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 > >>
View [10|25|50] records per page
|
